Advanced search
Publication Cover
Scandinavian Cardiovascular Journal Volume 38, 2004 - Issue 4
Submit an article Journal homepage
33
Views
8
CrossRef citations to date
0
Altmetric
Article

Blood platelet count and reactivity are associated with restenosis 6 months after coronary angioplasty

O. Johansen Department of Cardiology, Ullevaal University Hospital, Oslo, NorwayCorrespondence[email protected]
,
M. Brekke Department of Cardiovascular Radiology, Ullevaal University Hospital, Oslo, Norway
,
I. Seljeflot Centre for Clinical Research, Ullevaal University Hospital, Oslo, Norway
,
A. G. Semb Department of Cardiology, Aker University Hospital, Oslo, Norway
&
H. Arnesen Department of Cardiology, Ullevaal University Hospital, Oslo, Norway
Pages 211-215 | Received 24 Nov 2003, Accepted 24 Apr 2004, Published online: 12 Jul 2009

References

  • Serruys PW, Luijten HE, Beatt KJ, et al. Incidence of restenosis after successful coronary angioplasty: A time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1,2,3, and 4 months. Circulation 1988; 77: 361–371.
  • Lange RA, Willard JE, Hillis LD. Southwestern internal medicine conference: Restenosis: The Achilles heel of coronary angioplasty. Am J Med Sci 1993; 306: 265–275.
  • Koning R, Eltchaninoff H, Commeau P. et al. Stent placement compared with balloon angioplasty for small coronary arteries: In-hospital and 6-month clinical and angiographic results. Circulation 2001; 104: 1604–1608.
  • Dangas G, Fuster V. Management of restenosis after coronary intervention. Am Heart J 2001; 132: 1–36.
  • Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Nerem RM. The pathogenesis of atherosclerosis: An overview. Clin Cardiol 1991; 14 Suppl I: 1–16.
  • Lovqvist A, Emanuelsson H, Nilsson J, Lundqvist H, Carlsson J. Patho-physiological mechanisms for restenosis following coronary angioplasty: Possible preventive alternatives. J Intern Med 1993; 233: 215–226.
  • Chandrasekar B, Tanguay JF. Platelets and restenosis. J Am Coll Cardiol 2000; 35: 555–562.
  • Smyth DW, Martin JF, Michalis L, Bucknall CA, Jewitt DE. Influence of platelet size before coronary angioplasty on subsequent restenosis. Eur J Clin Invest 2001; 23: 361–367.
  • Tardif JC, Cote G, Lesperance J, et al. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group. N Engl J Med 1997; 337: 365–372.
  • Schnyder G, Roffi M, Pin R, et al. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 2001; 345: 1593–1600.
  • Okamoto S, Inden M, Setsuda M, Konishi T, Nakano T. Effects of trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, in preventing restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 1992; 123: 1439–1444.
  • Ross R, Bowen-Pope DF, Raines EW. Platelet-derived growth factor and its role in health and disease. Philos Trans R Soc Lond B Biol Sci 1990; 327: 155–169.
  • Johansen 0, Brekke M, Seljeflot I, Abdelnoor M, Amesen a n-3 fatty acids do not prevent restenosis after coronary angioplasty. Result from the CART study. J Am Coll Cardiol 1998; 33: 1619–1626.
  • Altman DG. Practical statistics for medical research. London: Chapman & Hall, 1996.
  • Anonymous. Epi Info 5.01a. In: Epi Info. Version 5.01a. Center for Disease Control Epidemiology Program Office, 1991.
  • Heldin CH, Westermark a Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 2001; 79: 1283–1316.
  • Bach R, Jung F, Kohsiek I, et al. Factors affecting the restenosis rate after percutaneous transluminal coronary angioplasty. Thromb Res 1994; 74 Suppl 1: 55–67.
  • Kotani M, Fukuda N, Ando H, et al. Chimeric DNA-RNA hammerhead ribozyme targeting PDGF A-chain mRNA specifically inhibits neointima formation in rat carotid artery after balloon injury. Cardiovasc Res 2003; 57: 265–276.
  • Fomitz GG, Nielsen P, Amtorp 0, et al. Impaired fibrinolysis determines the outcome of percutaneous transluminal coronary angioplasty (PTCA). Eur J Clin Invest 2001; 31: 586–592.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.